Status not kept up to date
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
NCT01378637 · AMES Technology · Updated 8 Dec 2016
- What is being tested
- AMES- Leg treatment
- For
- Stroke; Cerebrovascular Accident; Hemiparesis
- Kind of study
- Tests a treatment or device on volunteers. Phase 1 and Phase 2.
- Who can join
- Ages 18 years to 85 years. About 22 people. The full rules are on the registry page.
- Where
- United States (2 sites)
- When
- Starts or started Jan 2011, ends July 2017. Registered 22 June 2011.
- Results
- None posted yet.
In the researchers' words
The purpose of this protocol is to determine if individuals who had a stroke more than one year before entering the study and whose ankles remain substantially impaired are able to sense and move the affected leg better after 9-13 weeks of treatment with a robotic therapy device (AMES).
Sites
- Northwestern University/Rehabilitation Institute of ChicagoChicago, Illinois, United States
- Oregon Health and Science UniversityPortland, Oregon, United States